HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents.

by Michael McMahon, Kathryn H Campbell, A Kenneth MacLeod, Lesley A McLaughlin, Colin J Henderson, C Roland Wolf
Published 2014-01-01